At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 60 enrolled
Drug / intervention
Dexmedetomidine +1 moredrug
Likely dose
Dexmedetomidine 0.7 microgramfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Effect of Prophylactic Dexmedetomidine on Hemodynamic Disturbances During Double Lumen Endotracheal Intubation. A Double-blinded, Randomized, Placebo-Controlled Trial.
In Brief
A Phase 2 clinical trial evaluating Dexmedetomidine and Placebo for Intubation Complication and 5 related conditions. Completed, enrolled 60 participants across 1 site.
Detailed Summary
The purpose of this study is to evaluate the effect of dexmedetomidine on hemodynamic responses during laryngoscopy and double lumen endotracheal intubation and assess the adverse effect related to complications of dexmedetomidine.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsIntubation Complication, Tracheal Intubation Morbidity, Anesthesia Intubation Complication, Hypertension, High Blood Pressure, Tachycardia
CountriesThailand
Collaborators--
Timeline
Phase 2CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedFeb 2011
Enrollment StartMar 2011
Primary CompletionDec 2011
TodayJul 2026
First PostedFeb 4, 2011
Enrollment StartMar 1, 2011
Primary CompletionDec 1, 2011
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 15.4 years ago
Interventions
Dexmedetomidinedrug
dexmedetomidine 0.7 microgram per kilogram in saline 20 ml given within 10 minutes before intubation
Placebodrug
normal saline 20 ml( the same volume as dexmedetomidine) giving within 10 minutes.